A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia

Completed · Phase 1

Conditions studied: Acute Lymphocytic Leukemia, Leukemia

In brief

The pharmacokinetic behavior of vincristine in pediatric patients has not been well characterized. The present study will obtain detailed information on vincristine pharmacokinetics in patients being treated for standard risk ALL on CCG protocols 1952/1962. A limited sampling strategy will be developed, and the interpatient and intrapatient variability of vincristine pharmacokinetics in children will be studied. A correlation between vincristine neurotoxicity and vincristine pharmacokinetics will be sought.

Key facts

Study ID
NCT00001689
Run by
National Cancer Institute (NCI)
People needed
90
Starts
1998-01-01
Expected to finish
2003-11-01
Last updated by the study team
2008-03-04

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.